How to optimize real-world data with lab results for clinical trials & HEOR
Key benefits of real-world lab data for life sciences and pharma Real-world lab results enhance...
When billed and allowed amounts aren’t enough: HealthVerity proprietary market cost offering in taXonomy
A better way to measure healthcare costs in closed claims data This is the second post in our four-part taXonomy X blog series (part 1 here), and here we’ll discuss one of the most common pain points in closed claims analytics: costs. Specifically,...
Zombie Data: The silent threat to real-world data in life sciences
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial...
What’s Broken in Audience Targeting - And How to Fix It
The one constant in healthcare marketing is change, particularly in four key areas: Evolving...
Unlock open and closed claims data with taXOnomy: Claim better outreach
In the evolving world of real-world data (RWD), pharmaceutical companies are increasingly focused...
A guide to optimizing real-world data: Hospital chargemaster
In our series exploring the benefits, considerations and use cases for various types of real-world...
Advancing COVID-19 Research with the National Cancer Institute
Background of the CRWDi project While the COVID-19 pandemic is behind us, the virus remains a...
A guide to optimizing real-world data: Electronic medical records
The healthcare industry has moved away from paper charts and file folders in favor of electronic...
Beyond the numbers: indirect ways to assess patient matching accuracy metrics
Part 4: Indirect and qualitative metrics for matching accuracy [Part 4] of Matching Accuracy...
Unlock better outcomes with real-world closed claims data from taXonomy
As high-value therapies become the new norm,life sciences teams need closed claims data that...
The biomarker advantage
HealthVerity COO Andrew Goldberg recently sat down with Quest Diagnostics’ Director, Health...